Trinity Bio ADR (TRIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Sales | 7,570 | 15,856 | 15,152 | 15,843 | 14,704 |
| Cost of Goods | 5,662 | 10,979 | 9,844 | 10,109 | 9,182 |
| Gross Profit | 1,908 | 4,877 | 5,308 | 5,734 | 5,522 |
| Operating Expenses | 9,053 | 17,370 | 8,710 | 9,895 | 8,745 |
| Operating Income | -6,483 | -11,514 | -2,558 | -4,052 | -3,041 |
| Interest Expense | 2,309 | 3,381 | 3,084 | 2,836 | 264 |
| Other Income | 1 | -903 | 848 | 0 | 55 |
| Pre-tax Income | -8,791 | -15,798 | -4,794 | -6,888 | -3,250 |
| Income Tax | 6 | 585 | -35 | -131 | 67 |
| Net Income Continuous | -8,797 | -16,383 | -4,759 | -6,757 | -3,317 |
| Net Income | $-8,797 | $-16,956 | $-4,759 | $-6,757 | $-3,317 |
| EPS Basic Total Ops | -2.40 | -1.13 | -2.30 | -3.57 | -1.85 |
| EPS Basic Continuous Ops | -2.40 | -0.96 | -2.29 | -3.57 | -1.87 |
| EPS Diluted Total Ops | -2.40 | -1.13 | -2.30 | -3.57 | -1.85 |
| EPS Diluted Continuous Ops | -2.40 | -0.96 | -2.29 | -3.57 | -1.87 |
| EPS Diluted Before Non-Recurring Items | -2.40 | -5.10 | -2.15 | -2.75 | -1.85 |
| EBITDA(a) | $-5,845 | $-11,090 | $-1,961 | $-3,899 | $-2,350 |